The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 24, 2015

Filed:

May. 05, 2011
Applicants:

Edward L. Chan, Mt. Sinai, NY (US);

James Keller, Islip, NY (US);

Inventors:

Edward L. Chan, Mt. Sinai, NY (US);

James Keller, Islip, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C12Q 1/68 (2006.01); C07K 14/71 (2006.01); G01N 33/574 (2006.01); C07K 16/40 (2006.01); C12N 9/12 (2006.01); G01N 33/74 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C07K 14/71 (2013.01); G01N 33/57407 (2013.01); C07K 16/40 (2013.01); C12N 9/12 (2013.01); G01N 33/74 (2013.01); C07K 2319/00 (2013.01); C07K 2319/23 (2013.01); C07K 2319/42 (2013.01); C07K 2319/43 (2013.01); C07K 2319/60 (2013.01); G01N 2333/71 (2013.01); G01N 2800/56 (2013.01);
Abstract

Described herein are truncated EGF receptor polypeptides, nucleic acids encoding them, and methods of using them to help select a method of treatment for an EGFR-related cancer, to predict clinical outcome, and to detect micrometastases or minimal residual disease. High EGFR expression and phosphorylated EGFR predicts poor survival in head and neck cancer patients, but does not correlate with advanced stage disease. In our studies, we determined that clinical biological correlates are likely to be more accurate when different aspects of EGFR are evaluated in combination. We analyzed EGFR phosphorylation, expression and mutations in 60 primary head and neck tumors. We not only found that head and neck tumors with either truncated or activated EGFR tend to have higher tumor and nodal stage, but also discovered three EGFR truncations.


Find Patent Forward Citations

Loading…